Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Guillem Argilés
Efficacy of Sym004 in Patients With Metastatic Colorectal Cancer With Acquired Resistance to Anti-Egfr Therapy and Molecularly Selected by Circulating Tumor DNA Analyses
JAMA Oncology
Cancer Research
Oncology
Related publications
Circulating Tumor DNA to Monitor Treatment Response and Detect Acquired Resistance in Patients With Metastatic Melanoma
Oncotarget
Oncology
Emergence of KRAS Mutations and Acquired Resistance to Anti-Egfr Therapy in Colorectal Cancer
Nature
Multidisciplinary
EGFR Inhibitor as Second-Line Therapy in a Patient With Mutant RAS Metastatic Colorectal Cancer: Circulating Tumor DNA to Personalize Treatment
JCO Precision Oncology
Cancer Research
Oncology
Molecular Determinants of Anti-Egfr Sensitivity and Resistance in Metastatic Colorectal Cancer
British Journal of Cancer
Cancer Research
Oncology
Early Change in Circulating Tumor DNA as a Potential Predictor of Response to Chemotherapy in Patients With Metastatic Colorectal Cancer
Scientific Reports
Multidisciplinary
Dermatologic Toxicity Occurring During Anti-Egfr Monoclonal Inhibitor Therapy in Patients With Metastatic Colorectal Cancer: A Systematic Review
Clinical Colorectal Cancer
Oncology
Gastroenterology
Impact of STAT3 Phosphorylation on the Clinical Effectiveness of Anti-EGFR–Based Therapy in Patients With Metastatic Colorectal Cancer
Clinical Colorectal Cancer
Oncology
Gastroenterology
KRAS Mutation Analysis of Single Circulating Tumor Cells From Patients With Metastatic Colorectal Cancer
BMC Cancer
Cancer Research
Oncology
Genetics
Change in Circulating Tumor DNA After Hepatic Resection for Metastatic Colorectal Cancer
HPB
Hepatology
Gastroenterology